Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults

Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults

BackgroundMigraine is a neurological condition marked by frequent headaches, which tends to be accompanied by nausea and vomiting in severe instances. Injectable therapies for migraine, such as monoclonal antibodies that target calcitonin gene-related peptide (CGRP), have proven to be effective and...

Full description

Saved in:
Bibliographic Details
Main Authors: Adarsh Raja, Rabia Asim, Muhammad Hamza Shuja, Sandesh Raja, Tazheen Saleh Muhammad, Simran Bajaj, Abdul Hadi Ansari, Hamza Ali, Iffat Ambreen Magsi, Muhammad Hammad Faridi, Hamza Ali Hasnain Sheikh, Muhammad Junaid Imran, Muhammad Ahmed, Muhammad Sohaib Asghar
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-09-01
Series:Frontiers in Neurology
Subjects:
atogepant
CGRP
migraine
headache
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1468961/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1468961/full

Similar Items